Skip to main content

and
  1. No Access

    Article

    Genomics to select treatment for patients with metastatic breast cancer

    Cancer progression is driven in part by genomic alterations1. The genomic characterization of cancers has shown interpatient heterogeneity regarding driver alterations2, leading to the concept that generation of ...

    Fabrice Andre, Thomas Filleron, Maud Kamal, Fernanda Mosele, Monica Arnedos in Nature (2022)